These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 739933)

  • 21. The optimal therapeutic range in oral anticoagulation. History and proposal.
    Loeliger EA
    Thromb Haemost; 1979 Dec; 42(4):1141-52. PubMed ID: 396691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral anticoagulant therapy control: evidence that INR expression improves the inter-laboratory comparability of results--the Bologna oral anticoagulant control exercise.
    Palareti G; Coccheri S; Poggi M; Bonetti M; Cervi V; Mazzuca A; Savoia M; Veri L; Fiori F; Gaspari G
    Thromb Haemost; 1987 Oct; 58(3):905-10. PubMed ID: 3433253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Clin Chim Acta; 1985 Mar; 146(2-3):229H-233H. PubMed ID: 3987050
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of domestic thromboplastins with attested international indices of sensitivity in the treatment of thrombophilia].
    Kachalova ND; Klimovich LG; Berkovskiĭ AL; Prostakova TM; Kozlov AA
    Klin Lab Diagn; 2002 Jun; (6):13-6. PubMed ID: 12132368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Questions and answers on prothrombin time standardisation in oral anticoagulant control.
    Loeliger EA; Poller L; Samama M; Thomson JM; Van den Besselaar AM; Vermylen J; Verstraete M
    Thromb Haemost; 1985 Aug; 54(2):515-7. PubMed ID: 4082086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality control and oral anticoagulation.
    Preston FE
    Thromb Haemost; 1995 Jul; 74(1):515-20. PubMed ID: 8578516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The "therapeutic range" of the one-stage prothrombin time in the control of anticoagulant therapy: the effect of different thromboplastin preparations.
    Bailey EL; Harper TA; Pinkerton PH
    Can Med Assoc J; 1971 Nov; 105(10):1041-3 passim. PubMed ID: 5150206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Control of oral anticoagulation. Current concepts].
    Aguilar CA; Hurtado Monroy R; Gaspar Hernández J
    Rev Invest Clin; 1989; 41(4):371-4. PubMed ID: 2698502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thromboplastin and oral anticoagulant control.
    Poller L
    Br J Haematol; 1987 Sep; 67(1):116-7. PubMed ID: 3663518
    [No Abstract]   [Full Text] [Related]  

  • 30. Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH collaborative study on prothrombin time standardization.
    Loeliger EA; van Halem-Visser LP
    Thromb Haemost; 1979 Dec; 42(4):1115-27. PubMed ID: 542924
    [No Abstract]   [Full Text] [Related]  

  • 31. [Current biological surveillance of oral anticoagulant treatment].
    Helft G; Vacheron A; Samama MM
    Arch Mal Coeur Vaiss; 1995 Jan; 88(1):85-9. PubMed ID: 7646254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of freeze-dried plasma prepared from patients on oral anticoagulants.
    Brozović M; Howarth DJ; van Halem Visser LP; Loeliger EA
    J Clin Pathol; 1973 Nov; 26(11):857-63. PubMed ID: 4797328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Precision and accuracy of the international normalized ratio in oral anticoagulant control.
    van den Besselaar AM
    Haemostasis; 1996 Oct; 26 Suppl 4():248-65. PubMed ID: 8979131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of use of low international sensitivity index thromboplastins in prothrombin time testing.
    Ts'ao C; Swedlund J; Neofotistos D
    Arch Pathol Lab Med; 1994 Dec; 118(12):1183-7. PubMed ID: 7979911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring warfarin therapy in patients with lupus anticoagulants.
    Moll S; Ortel TL
    Ann Intern Med; 1997 Aug; 127(3):177-85. PubMed ID: 9245222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term stability of international reference preparations for thromboplastins.
    van den Besselaar AM; Hermans J; Beeser H; Loeliger EA
    Br J Haematol; 1988 Mar; 68(3):321-8. PubMed ID: 3355790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Standardization of the prothrombin time for monitoring orally administered anticoagulant therapy with use of the international normalized ratio system.
    Nichols WL; Bowie EJ
    Mayo Clin Proc; 1993 Sep; 68(9):897-8. PubMed ID: 8371608
    [No Abstract]   [Full Text] [Related]  

  • 38. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
    van den Besselaar AM
    J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective double-blind clinical trial of bovine, human, and rabbit thromboplastins in monitoring long-term oral anticoagulation.
    Boekhout-Mussert MJ; van der Kolk-Schaap PJ; Hermans J; Loeliger EA
    Am J Clin Pathol; 1981 Mar; 75(3):297-303. PubMed ID: 7010990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain.
    van den Besselaar AMHP; Chantarangkul V; Angeloni F; Binder NB; Byrne M; Dauer R; Gudmundsdottir BR; Jespersen J; Kitchen S; Legnani C; Lindahl TL; Manning RA; Martinuzzo M; Panes O; Pengo V; Riddell A; Subramanian S; Szederjesi A; Tantanate C; Herbel P; Tripodi A
    J Thromb Haemost; 2018 Jan; 16(1):142-149. PubMed ID: 29065247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.